Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma

por Zhou, Yu-bo, Zhang, Yang-ming, Huang, Hong-hui, Shen, Li-jing, Han, Xiao-feng, Hu, Xiao-bei, Yu, Song-da, Gao, An-hui, Sheng, Li, Su, Ming-bo, Wei, Xiao-li, Zhang, Yue, Zhang, Yi-fan, Gao, Zhi-wei, Chen, Xiao-yan, Nan, Fa-jun, Li, Jia, Hou, Jian
Publicado 2021